serena williams and glp 1 Inside Williams' partnership with Ro for GLP-1s Serena Williams is returning to

Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes

For some patients, a GLP-1 or related medication may be appropriate

BMI Over 35 No additional questions

Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026

According to our research, it has been proved for the first time that berberine can improve T2DM by promoting the synergistic effect of intestinal-islet GLP-1/GLP-1R/PKA signal pathway

P =0.89), prostate cancer (RR, 0.53